Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases
Trials Unlikely to Show if COVID-19 Vaccine Prevents Severe Cases

A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

A vaccine expert explains that such answers likely won’t come until a vaccine has already been approved and administered to millions of people.

pharma & biotech
NYU Langone to Drop Sackler Name from Biomedical Institute
NYU Langone to Drop Sackler Name from Biomedical Institute
Max Kozlov | Oct 26, 2020
The decision comes after Purdue Pharma, founded by the Sackler family, announced it would plead guilty to federal criminal charges for its role in the opioid epidemic.
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Catherine Offord | Sep 3, 2020
A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.
Last Chance to Enter Our Annual Top 10 Innovations Contest
Last Chance to Enter Our Annual Top 10 Innovations Contest
The Scientist Staff | Aug 18, 2020
The deadline is this Friday to submit your new product and have a chance at being selected for a coveted spot in The Scientist’s 2020 competition.
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Catherine Offord | Aug 11, 2020
Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.
Thwarting a Pandemic: COVID-19 Vaccine Strategies
Thwarting a Pandemic: COVID-19 Vaccine Strategies
The Scientist Creative Services Team | Aug 6, 2020
Download this poster to learn about promising vaccine candidates for COVID-19!
Starting a New Lab
Starting a New Lab
The Scientist Creative Services Team | Aug 6, 2020
Advice for new principal investigators starting their first research laboratories!
Activities Discovered for Some Inactive Drug Ingredients
Activities Discovered for Some Inactive Drug Ingredients
Ruth Williams | Jul 23, 2020
Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.
How the Pharma Industry Pulled Off the Pivot to COVID-19
How the Pharma Industry Pulled Off the Pivot to COVID-19
Diana Kwon | Jul 13, 2020
The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.